These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7503632)

  • 1. 2-Chloro-2'-deoxyadenosine (2-CdA) treatment in a patient with Waldenström's macroglobulinaemia complicated by severe neutrocytopenia.
    Zaucha JM; Ciesielski D; Grieb P; Hellmann A
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):35-7. PubMed ID: 7503632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia.
    Delannoy A; Ferrant A; Martiat P; Bosly A; Zenebergh A; Michaux JL
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):317-20. PubMed ID: 7971252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK).
    Betticher DC; Hsu Schmitz SF; Ratschiller D; von Rohr A; Egger T; Pugin P; Stalder M; Hess U; Fey MF; Cerny T
    Br J Haematol; 1997 Nov; 99(2):358-63. PubMed ID: 9375754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cladribine for Waldenström's macroglobulinaemia.
    Delannoy A; Van Den Neste E; Michaux JL; Bosly A; Ferrant A
    Br J Haematol; 1999 Mar; 104(4):933-4. PubMed ID: 10192467
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-Chlorodeoxyadenosine treatment of Waldenström's macroglobulinemia--the analysis of own experience and the review of literature.
    Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Hellmann A
    Med Sci Monit; 2000; 6(4):740-5. PubMed ID: 11208402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory Waldenström's macroglobulinaemia responsive to 2-chlorodeoxyadenosine and mycophenolate mofetil.
    Gladstone DE
    Leuk Res; 2008 Sep; 32(9):1487-8. PubMed ID: 18378308
    [No Abstract]   [Full Text] [Related]  

  • 7. 2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia.
    Weber DM; Dimopoulos MA; Delasalle K; Rankin K; Gavino M; Alexanian R
    Semin Oncol; 2003 Apr; 30(2):243-7. PubMed ID: 12720145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked increase in serum IgM during treatment of Waldenstrom's macroglobulinemia with cladribine.
    Krishna VM; Carey RW; Bloch KJ
    N Engl J Med; 2003 May; 348(20):2045-6. PubMed ID: 12748329
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia.
    Hellmann A; Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Robak T
    Eur J Haematol; 1999 Jul; 63(1):35-41. PubMed ID: 10414453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of Waldenström's macroglubulinemia related isolated neutropenia by immunochemotherapy.
    van Gelder M; van Marion A; Goossens V; Bommer M; Leblond V
    Am J Hematol; 2011 Apr; 86(4):380-2. PubMed ID: 21442645
    [No Abstract]   [Full Text] [Related]  

  • 11. First-line treatment of Waldenström's disease with cladribine. Arbeitsgemeinschaft Medikamentöse Tumortherapie.
    Fridrik MA; Jäger G; Baldinger C; Krieger O; Chott A; Bettelheim P
    Ann Hematol; 1997 Jan; 74(1):7-10. PubMed ID: 9031608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
    Amin CJ; Rabinowitz I
    Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PNP with Waldenström's macroglobulinaemia.
    Perera GK; Devereux S; Mufti G; Salisbury J; Creamer D
    Clin Exp Dermatol; 2005 Jan; 30(1):27-9. PubMed ID: 15663497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?
    Ling S; Joshua DE; Gibson J; Young G; Iland H; Watson G; Ho PJ
    Am J Hematol; 2006 Feb; 81(2):110-4. PubMed ID: 16432856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waldenstrom's macroglobulinaemia with intracerebral haemorrhage.
    Khan GQ; Hassan DG; Masood T; Khan AR
    J Postgrad Med; 2000; 46(3):187-8. PubMed ID: 11298468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of sarcoidosis and Waldenström's macroglobulinemia].
    Collet E; Boulitrop-Morvan C; Dalac S; Camus P; Lambert D
    Ann Dermatol Venereol; 1992; 119(12):971-4. PubMed ID: 1304690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of meningeal Waldenström's macroglobulinemia to 2-chlorodeoxyadenosine.
    Richards AI
    J Clin Oncol; 1995 Sep; 13(9):2476. PubMed ID: 7666113
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diffuse large cell lymphoma and colon adenocarcinoma in patient with Waldenström's macroglobulinaemia].
    Radojković M; Ristić S; Colović N; Cemerikić-Martinović V; Colović M
    Srp Arh Celok Lek; 2011; 139(1-2):95-8. PubMed ID: 21568089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida tropicalis and Penicillium marneffei mixed fungaemia in a patient with Waldenström's macroglobulinaemia.
    Wong SS; Woo PC; Yuen KY
    Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):132-5. PubMed ID: 11305468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.